SCHEMBL2555641

SCHEMBL2555641

CCCCCCCCCCCCCCC(C(=O)O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 2/20 0.54
NAAA Q02083 2/20 0.50
ASAH1 Q13510 2/20 0.50
ALDH1A1 P00352 2/20 0.50
ACER2 Q5QJU3 1/20 0.50
GPR84 Q9NQS5 3/20 0.48
FFAR1 O14842 1/20 0.48
LMNA P02545 1/20 0.48
CYP2C19 P33261 1/20 0.47
MAPT P10636 1/20 0.47
LCK P06239 1/20 0.47
PPARD Q03181 1/20 0.47
ZDHHC20 Q5W0Z9 1/20 0.47
ZDHHC2 Q9UIJ5 1/20 0.47
POLB P06746 2/20 0.46
CNR2 P34972 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2554342 1.00 TBXAS1 (0.54) TBXAS1NAAAASAH1ALDH1A1ACER2
SCHEMBL1290373 1.00 TBXAS1 (0.54) TBXAS1NAAAASAH1ALDH1A1ACER2
SCHEMBL2551104 1.00 TBXAS1 (0.54) TBXAS1NAAAASAH1ALDH1A1ACER2
SCHEMBL2552091 1.00 TBXAS1 (0.54) TBXAS1NAAAASAH1ALDH1A1ACER2
SCHEMBL1518057 1.00 TBXAS1 (0.54) TBXAS1NAAAASAH1ALDH1A1ACER2
SCHEMBL2550963 1.00 TBXAS1 (0.54) TBXAS1NAAAASAH1ALDH1A1ACER2
SCHEMBL2552649 1.00 TBXAS1 (0.54) TBXAS1NAAAASAH1ALDH1A1ACER2
SCHEMBL2554332 1.00 TBXAS1 (0.54) TBXAS1NAAAASAH1ALDH1A1ACER2
SCHEMBL2548840 1.00 TBXAS1 (0.54) TBXAS1NAAAASAH1ALDH1A1ACER2
SCHEMBL2550077 1.00 TBXAS1 (0.54) TBXAS1NAAAASAH1ALDH1A1ACER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3425020-B1 DEVICE COMPRISING QUANTUM DOT COMPOSITIONS NANOCO TECHNOLOGIES LTD (GB) 2021-07-28 EP claimed
EP-3122840-B1 QUANTUM DOT COMPOSITIONS NANOCO TECHNOLOGIES LTD (GB) 2018-08-22 EP claimed
CN-103119208-A A biocidal polyolefin yarn with 3-12 filaments VESTERGAARD FRANDSEN SA 2013-05-22 CN claimed
WO-2011124228-A1 A BIOCIDAL POLYOLEFIN YARN WITH 3-12 FILAMENTS VESTERGAARD FRANDSEN SA (CH) 2011-10-13 WO claimed
WO-2011124227-A1 BIOCIDAL ACID-ADJUSTED POLYMER WITH POLYPROPYLENE VESTERGAARD FRANDSEN SA (CH) 2011-10-13 WO claimed
EP-2731993-B1 EPOXY RESIN COMPOUND AND RADIANT HEAT CIRCUIT BOARD USING THE SAME LG INNOTEK CO LTD (KR) 2023-08-30 EP disclosed
US-11628394-B2 Gas separation membrane module ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-04-18 US disclosed
US-9650587-B2 Stabilized blends containing antioxidants THE LUBRIZOL CORPORATION (US) 2017-05-16 US disclosed
US-9631160-B2 Stabilized blends containing friction modifiers THE LUBRIZOL CORPORATION (US) 2017-04-25 US disclosed
CN-103620000-B Stable mixtures containing friction modifiers 路博润公司 2017-03-15 CN disclosed
US-9540581-B2 Stabilized blends containing friction modifiers THE LUBRIZOL CORPORATION (US) 2017-01-10 US disclosed
US-20160319212-A1 STABILIZED BLENDS CONTAINING ANTIOXIDANTS LUBRIZOL CORP (US) 2016-11-03 US disclosed
CN-103119208-A A biocidal polyolefin yarn with 3-12 filaments VESTERGAARD FRANDSEN SA 2013-05-22 CN disclosed
WO-2012162027-A1 STABILIZED BLENDS CONTAINING FRICTION MODIFIERS THE LUBRIZOL CORPORATION (US) 2012-11-29 WO disclosed
WO-2012162219-A1 STABILIZED BLENDS CONTAINING FRICTION MODIFIERS THE LUBRIZOL CORPORATION (US) 2012-11-29 WO disclosed
WO-2012162020-A1 STABILIZED BLENDS CONTAINING ANTIOXIDANTS THE LUBRIZOL CORPORATION (US) 2012-11-29 WO disclosed
WO-2012162282-A1 STABILIZED BLENDS CONTAINING FRICTION MODIFIERS THE LUBRIZOL CORPORATION (US) 2012-11-29 WO disclosed
WO-2011124227-A1 BIOCIDAL ACID-ADJUSTED POLYMER WITH POLYPROPYLENE VESTERGAARD FRANDSEN SA (CH) 2011-10-13 WO disclosed
EP-1751126-A1 ALKYL CARBAMATE-SUBSTITUTED BUTYROLACTONES SERVING AS LIPASE INHIBITORS Solvay Pharmaceuticals GmbH (DE) 2007-02-14 EP disclosed
WO-2005080366-A1 ALKYL CARBAMATE-SUBSTITUTED BUTYROLACTONES SERVING AS LIPASE INHIBITORS SOLVAY PHARMACEUTICALS GMBH (DE) 2005-09-01 WO disclosed